North Hills - 135 Cumberland Road, Suite 105 15237
South Hills - 2893 Banksville Road 15216
Phone - (NH) 412-364-1886 (SH) 412-364-1886
Toll Free - 855-HOPE360

Home / Recent News (page 12)

Recent News

Depressive thoughts affect memory

Depression and poor concentration/memory go hand-in-hand, further emphasizing the need for prompt treatment. Read more

Read More »

Circumcision and autism? Really?

Circumcision May Double The Chance Of Autism, Says Controversial New Study. Read more

Read More »

Does ‘dyslexia’ disable teachers?

Research suggests that preconceived notions about dyslexia may contribute to a classroom self-fulfilling prophecy of a child’s lack of a positive response to remediation. I tell parents to never use the word “dyslexia” when talking to school teachers or officials. Instead, use the term ‘learning disability’ or ‘reading disability’; which tends to be much more readily understood, accepted, and managed by school staff. If you use the term “dyslexia”, you’ll be told that the school district does not ‘treat’ that condition and you need to go elsewhere for help. However, if you use the aforementioned terms, you’re far more likely to receive help and supportive services from the teacher and school officials. See my blog on the subject ( Read More

Read More »

How To Help Children Control Their Emotions, Reduce Anxiety and Boost Attention

Playing an instrument teaches valuable skills for children including focus, attention, perseverance, delay of gratification, frustration tolerance, and the importance of practice. Recent research also shows that playing an instrument increases the brain’s cortical thickness and enhances synaptic efficiency which leads to even better focus, attention, perseverance…  There is a snow-ball effect in that respect. Read more about this phenomenon

Read More »

Phase III GXR study shows improvement in core symptoms of ADHD

Phase III study of Guanfacine (Tenex) shown to significantly improve core symptoms of ADHD. Results published in European Neuropsychopharmacology demonstrate the efficacy of the Attention-Deficit/Hyperactivity Disorder (ADHD) medication, guanfacine hydrochloride extended release (GXR). The Phase III study (SPD503-316) shows a significant reduction in ADHD core symptoms and global functioning in children and adolescents living with the disorder when treated with GXR.1 Read more

Read More »